Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as healthcare leaders navigate a changed world.' Now in its seventh year, the Future Health Index 2022 report, based on proprietary research from almost 3,000 respondents conducted across 15 countries, explores how healthcare leaders are harnessing the power of data and digital technology as they look to address their key challenges coming out of the pandemic.
The 2022 report paints a picture of a sector that is radically re-evaluating priorities as it strives to deliver improved patient care. "As we emerge from the pandemic, healthcare leaders worldwide are embarking on a reboot," said Jan Kimpen, Chief Medical Officer, Philips. "Many are refocusing on both new and existing priorities, from addressing staff shortages and extending care delivery, to leveraging big data and predictive analytics."
Staff satisfaction and retention top the priority list for healthcare leaders
Globally, around one in three healthcare leaders (30%) say staff satisfaction and retention combined is a top priority. However, what is driving this priority differs from country to country. For example, in the USA and Germany staff satisfaction and retention is driven by the 'great resignation'. In India, the ever-increasing demand for more healthcare professionals is the predominant driver. Across all countries, healthcare leaders' investments in digital technologies will help to improve the staff experience.
While data is seen as an enabler, the potential of predictive analytics remains unfulfilled
Healthcare leaders have confidence in predictive analytics with 71% trusting predictive analytics in clinical settings, and 72% in operational settings. Overall, healthcare leaders see the positive impact of predictive analytics, particularly in health outcomes, patient experience and staff experience, and more than half (56%) have already adopted, or are in the process of adopting, predictive analytics in some form. However, uptake remains uneven, with a marked difference in adoption among developed and emerging countries (65% vs 48%). The FHI 2022 research also indicates even those who are furthest along in adoption of predictive analytics are not leveraging the full potential of the technology.
Overcoming the barriers to effective data use is crucial to gain widespread adoption
While confident in the value of data, healthcare leaders remain frustrated by ongoing barriers to effective data usage, including siloed data (51%) and infrastructure limitations (23%). With cyberattacks increasingly targeting the healthcare sector, one in five (21%) cite concerns about data privacy and security as a top barrier to using data to its full potential. They also say greater data security and privacy systems and protocols are the top way to strengthen their trust in predictive analytics in both clinical (38%) and operational (35%) settings. Additionally, only 19% of healthcare leaders have all the internal expertise they need to fully use the data they have available, while 24% cite the availability of data specialists as a top factor in helping to better utilize data. Despite seeing the potential of data, as a result of these frustrations, nearly half of healthcare leaders (48%) view data as more of a burden than an asset today.
Leaders are fast-tracking social responsibility
The pandemic threw a spotlight on health inequality and healthcare leaders are responding. One-quarter (25%) see addressing health inequality as a priority today, compared to only 12% in 2021. Technology can play a part: two in three healthcare leaders (68%) agree that predictive analytics can have a positive impact on helping to reduce health disparities by providing fast and accurate insights on risk scores to help identify more vulnerable groups for proactive planning to help better manage community health issues like disease outbreaks, cancer incidences and more.The 2022 report also sees healthcare leaders fast-tracking their sustainability plans. In 2021, just 4% of healthcare leaders worldwide were prioritizing environmental sustainability. This figure has jumped to 24% today; a more than six-fold increase year-over-year.
Since 2016, Philips has conducted original research to help determine the readiness of countries to address global health challenges and build efficient and effective health systems. For details on the Future Health Index methodology and to access the Future Health Index 2022 report in its entirety, please visit https://www.philips.com/a-w/about/news/future-health-index/reports/2022/healthcare-hits-reset.html
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries.